Global Eosinophilic Asthma Treatment Market Overview
Eosinophilic Asthma Treatment Market was valued at US$ 12.5 Billion in 2024 and is projected to grow at a CAGR of 33.7% to reach US$ 229 Billion by 2034.
Prophecy Market Insights has recently published its insights on “Global Eosinophilic Asthma Treatment Market” for the forecast period of 2018-2029. The market is segmented into By Type of Medication (Long Term Control Medications, Short Acting Medications, and Biologic Therapies), By Route of Administration (Oral, Rectal, Intravenous, and Nasal), and By Region
Increasing air pollution is causing many lung diseases such as asthma which is the major factor driving the growth of the global eosinophilic asthma treatment market. Also, decreasing immunity in people due to smoking habits and unhealthy eating habits may lead to eosinophilic asthma and hence is propelling the target market growth as well. In addition, susceptibility of allergies within individuals has boosted the target market growth. Furthermore, rise in the new biologic treatments such as monoclonal antibodies are augmenting the target market growth.
North America to grow at the highest CAGR during the forecast period
North America is expected to be the dominating market over the forecast period owing to the increasing incidences of allergens causing the eosinophilic asthma. In addition, high adoption rate of eosinophilic asthma treatment is driving the target market growth in the region. Europe is expected to grow at a rapid pace over the forecast period owing to the acquisition of product portfolios, increase in research activities by pharmaceutical companies, and product approvals & market authorization by regulatory bodies. Apart from this, Asia-Pacific is expected to emerge as the strong markets over the forecast period. Extensive awareness about the eosinophilic asthma treatment is boosting the target market growth in the region.
The research scope provides comprehensive market size, and other in-depth market information details such as, market growth supporting factors, restraining factors, trends, opportunities, market risk factors, market competition, product and services advancements and launches, product/services related regulations overview, and recent developments for the mentioned forecast period. In addition, the report provides key examination of market players operating in the specific market and analysis and outcomes related with the target market for more than 20 countries.
In the current research scope 2018 is considered as base year and 2019 is estimated year for market value/volume calculations. The report offers market estimates for the forecast period – 2019 to 2029. The report provides factual inputs and analysis based on primary and secondary research, which includes insights gained through in-depth interviews with primary research participants. Also, the data is gathered from authentic secondary sources and is verified by key opinion leaders in the target market. The in-house research is applied on gathered information to provide more accurate data points and reduce the margin of error. The in-house research and analysis efforts include various tools and 360o data analysis methodology.
The global eosinophilic asthma treatment market report segments the market on the basis of type of medication, route of administration, and region.
The report expected to answer various target market related questions and offers insights on:
- Definition, description, overview of market growth influencing factors, and forecast for the target market
- Scope for related market in the forecast period
- Analysis and outcome for the global eosinophilic asthma treatment market by segment and region followed by countries
- Market segmentation, dominating segment and region followed by country along with market value, share, Y-o-Y growth, CAGR, forecast, and contribution in the market
- Key market player profiles, their recent developments, strategies, financial details, key competencies, presence by region, and product portfolio
- Valuable insights, data, and forecast that can be referenced to plan business strategies, to tap market opportunities, understand business related risks, derive business goals, to recognize trends, and understand target customers/end users
- Insights on recent technologies, pipeline products, regulations related with target market, market investment, and offers insights on political and economic factors that may influence market growth
- PEST Analysis, PORTER’s five forces analysis, opportunity map analysis, drivers and restraints impact analysis, and market attractiveness index
Competitive Analysis
Advancements in the product as well as in manufacturing process, product launches, and strategic partnerships are some trends witnessed in the global eosinophilic asthma treatment market. Key players have adopted mergers & acquisitions and new product developments to strengthen their positions in the global eosinophilic asthma treatment market. For instance, in May, 2019, Lupin Pharmaceuticals., Inc. launched asthma treatment drug in the United States.
- Johnson & Johnson Inc.
- Novartis Corporation
- Lupin Pharmaceuticals., Inc.
- Pfizer Inc.
- Sanofi S.A.
- Merck & Co Inc.
- GlaxoSmithKline LLC
- AstraZeneca Pharmaceuticals LP
- Bayer AG
- Gilead Sciences, Inc.
Prophecy Market Insights offers required customization on this report according to specific business requirements.
Global Eosinophilic Asthma Treatment Market Table of Contents
Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
Market Preview
- Executive Summary
- Key Findings—Global Outlook for medical carts Strategies
- Key Questions this Study will Answer
- Market Snippet, By Type
- Market Snippet, By Route of Administration
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restrains
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
Eosinophilic Asthma Treatment Market, By Type, Forecast Period up to 10 Years, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Long Term Control Medications
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Short Acting Medications
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Biologic Therapies
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Eosinophilic Asthma Treatment Market, By Route of Administration, Forecast Period up to 10 Years, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Oral
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Rectal
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Intravenous
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Nasal
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Eosinophilic Asthma Treatment Market, By Region, Forecast Period up to 10 Years, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Regional Trends
- North America
- Market Size and Forecast (US$ Bn), By Type, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By By Route of Administration, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Bn), By Type, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By By Route of Administration, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Bn), By Type, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By By Route of Administration, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Bn), By Type, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By By Route of Administration, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Bn), By Type, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By By Route of Administration, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- GCC
- Israel
- South Africa
- Rest of Middle East
Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
Company Profiles
- Johnson & Johnson Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Novartis Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Lupin Pharmaceuticals., Inc.
- Lupin Pharmaceuticals. Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Cosucra
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Merck & Co Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- GlaxoSmithKline LLC
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- AstraZeneca Pharmaceuticals LP
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Bayer AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Gilead Sciences, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
The Last Word
- Future Impact
- About Us
- Contact
FAQs
The eosinophilic asthma treatment market report segments the market on the basis of type of medication, route of administration, and region.
The development of targeted biologics for eosinophilic asthma, the exploration of precision medicine approaches, and the increasing focus on combination therapies, presenting significant opportunities in the global Eosinophilic Asthma Treatment Market.
The rising prevalence of eosinophilic asthma, advancements in understanding asthma pathophysiology, the demand for personalized treatment options, and the growing adoption of biologics targeting specific inflammatory pathways in asthma management.
North America is expected to dominate the Eosinophilic Asthma Treatment Market, driven by a well-established healthcare system, a high prevalence of asthma cases, and significant research and development activities in the region.
Johnson & Johnson Inc., Novartis Corporation, Lupin Pharmaceuticals., Inc., Pfizer Inc., Sanofi S.A., Merck & Co Inc., GlaxoSmithKline LLC, AstraZeneca Pharmaceuticals LP, Bayer AG, Gilead Sciences, Inc.,